Why the study?
Does admission NPAR predict mortality in critically ill patients with cardiogenic shock?
Does admission NPAR predict mortality in critically ill patients with cardiogenic shock?
Admission NPAR may serve as a novel prognostic marker for short- and long-term mortality in patients with cardiogenic shock.
Supports NPAR for risk stratification in cardiogenic shock; hypothesis-generating and requires prospective validation before practice change.
Admission NPAR was independently associated with in-hospital, 30-day, and 365-day mortality in critically ill patients with CS.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: